Equities researchers at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Bausch Health ...

Equities research analysts at Zacks Research lowered their Q1 2025 earnings estimates for Occidental Petroleum in a research ...

A recent ransomeware attack targeted Zacks, an American investment firm, and a cybercriminal claimed to have stolen records ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC), ...

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Zacks Investment Research recently disclosed that it suffered a data breach that compromised the sensitive personal data of millions of individuals ...

ACM Research, Inc. (ACMR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

The fund pursues its investment objectives by applying a hybrid research process, which uses both quantitative and qualitative criteria. The Advisor uses the Zacks Rank, a proprietary model ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co. and ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time scorecard for the Q4 earnings season and new research reports on 16 ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.